{
    "pmcid": "10886287",
    "qa_pairs": {
        "What future improvement does the paper suggest for DL models like AlphaFold-Multimer?": [
            "Incorporating evolutionary sequence information.",
            "Increasing the speed of protein synthesis.",
            "Enhancing the resolution of electron microscopy images.",
            "Developing new types of nanobodies."
        ],
        "What is a noted limitation of AlphaFold-Multimer when predicting protein interactions?": [
            "Handling large protein complexes due to memory constraints.",
            "Predicting small molecule interactions.",
            "Generating accurate sequence alignments.",
            "Modeling single-chain proteins."
        ],
        "What is the primary focus of the paper regarding the use of deep learning in antibody design?": [
            "Enhancing antibody-antigen interactions, particularly for SARS-CoV-2.",
            "Developing new vaccines for SARS-CoV-2.",
            "Improving the manufacturing process of antibodies.",
            "Analyzing the genetic sequences of SARS-CoV-2."
        ],
        "Which region of antibodies is mentioned as challenging for AlphaFold-Multimer in Ab\u2013Ag binding prediction?": [
            "CDR-H3 region.",
            "Variable light chain region.",
            "Constant heavy chain region.",
            "Fc region."
        ],
        "Which tool is highlighted for its ability to predict multimeric protein structures in the context of SARS-CoV-2 nanobody design?": [
            "AlphaFold-Multimer.",
            "Rosetta.",
            "Hierarchical Structure Refinement Network.",
            "Threading methods."
        ]
    }
}